References
- Chandler A B., Hand R A. Phagocytized platelets: a source of lipids in human thrombi and atherosclerotic plaques. Science 1961; 134: 946–7
- Jørgensen L, Rowsell H C., Hovig T, Mustard J F. Resolution and organization of platelet-rich mural thrombi in carotid arteries of swine. Am J Pathol 1967; 51: 681–719
- Jørgensen L, Svendsen E. (1978) Endothelial cell injury. International Conference on Atherosclerosis, Milan, 1977, L A. Carlson, R Paoletti, C R. Sirtori, G Weber. Raven Press, New York, 561–6
- Mustard J F., Packham M A., Kinlough-Rathbone R L. Platelets and atherosclerosis. Atherosclerosis: Mechanisms and Approaches to Therapy, N E. Miller. Raven Press, New York 1983; 29–43
- McGill H C., Jr. Persistent problems in the pathogenesis of atherosclerosis. Arteriosclerosis 1984; 4: 443–51
- Ross R. The pathogenesis of atherosclerosis–an update. N Engl J Med 1986; 314: 488–500
- Faggiotto A, Ross R. Studies of hypercholesterolemia in the nonhuman primate. II. Fatty streak conversion to fibrous plaque. Arteriosclerosis 1984; 4: 341–56
- Deuel T F., Senior R M., Huang J S., Griffin G L. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J Clin Invest 1982; 69: 1046–9
- Sakamoto H, Firkin F. Characterization of leucocyte phagocytic stimulatory material released by activated human platelets. Br J Haematol 1984; 57: 49–60
- Minghetti L, Bartolini G, Orlandi M, et al. Purification and partial characterization of serum monocytotropic factor, a platelet-derived cyclooxy-genase-inducing polypeptide. Biochim Biophys Acta 1988; 958: 315–22
- McEver R P. GMP-140: a receptor for neutrophils and monocytes on activated platelets and endothelium. J Cell Biochem 1991; 45: 156–61
- Mencia-Huerta J M., Benveniste J. Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol 1979; 9: 409–15
- Sánchez-Crespo M, Alonso F, Egido J. Platelet-activating factor in anaphylaxis and phagocytosis. I. Release from human peripheral polymorphonuclears and monocytes during the stimulation by ionophore A23187 and phagocytosis but not from degranulating basophils. Immunology 1980; 40: 645–55
- Arnoux B, Duval D, Benveniste J. Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis. Eur J Clin Invest 1980; 10: 437–41
- Aviram M, Rosenblat M, Brook J G. Secretory products from human monocyte-derived macrophages enhance platelet aggregation. Metabolism 1991; 40: 270–4
- van Ginkel C JW, van Aken W G., Oh J IH, Vreeken J. Stimulation of monocyte procoagulant activity by adherence to different surfaces. Br J Haematol 1977; 37: 35–45
- Østerud B, Lindahl U, Seljelid S. Macrophages produce blood coagulation factors. FEBS Lett 1980; 120: 41–3
- Weidemann M J., Peskar B A., Wrogemann K, Rietschel E T., Staudinger H, Fischer H. Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type of prostaglandins, of chemiluminescence. FEBS Lett 1978; 89: 136–40
- Pawlowski N A., Kaplan G, Hamill A I., Cohn Z A., Scott W A. Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures. J Exp Med 1983; 158: 393–412
- Djaldetti M, Fishman P. Satellitism of platelets to monocytes in a patient with hypogammaglobuli-naemia. Scand J Haematol 1978; 21: 305–8
- Williams W R., Cavolina F, Williams W J. Platelet binding in mononuclear cell preparations from peripheral blood. Br J Exp Pathol 1983; 64: 451–5
- Fujita T, Kashimura M, Adachi K. Scanning electron microscopy and terminal circulation. Experientia 1985; 41: 167–79
- Jennings L K., Ashmun R A., Phillips D R., Fitzgerald L A., Dockter M E. Binding of human platelets to circulating blood monocytes occurs after venipuncture and is inhibited by prostacyclin (abstract). Thromb Haemost 1985; 54: 232
- Larsen E, Palabrica T, Sajer S, Gilbert G E., Wagner D D., Furie B C., Furie B. PADGEM-dependent adhesion of platelets to monocytes and neutrophils is mediated by a lineage-specific carbohydrate, LNF III (CD 15). Cell 1990; 63: 467–74
- Vainer H. The platelet populations. Adv Exp Med Biol 1972; 34: 191–217
- Cieslar P, Greenberg J P., Rand M L., Packham M A., Kinlough-Rathbone R L., Mustard J F. Separation of thrombin-treated platelets from normal platelets by density-gradient centrifugation. Blood 1979; 53: 867–74
- Gear A RL. Preaggregation reactions of platelets. Blood 1981; 58: 477–90
- Rand M L., Packham M A., Mustard J F. Survival of density subpopulations of rabbit platelets: use of 51 Cr- or 111in-labeled platelets to measure survival of least dense and most dense platelets concurrently. Blood 1983; 61: 362–7
- van Oost B, van Hien-Hagg I H., Timmermans A PM, Sixma J J. The effect of thrombin on the density distribution of blood platelets. Detection of activated platelets in the circulation. Blood 1983; 62: 433–8
- Packham M A., Perry D W., Kinlough-Rathbone R L., et al. Effects on the buoyant density of rabbit platelets of ADP and agents that increase the concentration of cyclic AMP. Blood 1985; 65: 564–70
- Kornecki E, Ehrlich Y H., Lenox R H. Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodia-zepines. Science 1984; 226: 1454–6
- Ardlie N G., Packham M A., Mustard J F. Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol 1970; 19: 7–17
- Kinlough-Rathbone R L., Packham M A., Mustard J F. Platelet aggregation. Zimmerman Methods in Hematology. Measurements of Platelet Function, L A. Harker. Churchill Livingstone, Edinburgh 1983; 64–91
- Reimers H J., Allen D J., Feuerstein I A., Mustard J F. Transport and storage of serotonin by thrombin-treated platelets. J Cell Biol 1975; 65: 359–72
- Myrvik Q N., Leake E S., Fariss B. Studies on pulmonary alveolar macrophages from the normal rabbit: a technique to procure them in a high state of purity. J Immunol 1961; 86: 128–36
- Mørland B, Kaplan G. Macrophage activation in vivo and in vitro. Exp Cell Res 1977; 108: 279–88
- Bull B S., Zucker M B. Changes in platelet volume produced by temperature, metabolic inhibitors, and aggregating agents. Proc Soc Exp Biol Med 1965; 120: 296–301
- O'Brien J R., Heywood J B. Effect of aggregating agents and their inhibitors on the mean platelet shape. J Clin Path. 1966; 19: 148–53
- Born G VR. Observations on the change in shape of blood platelets brought about by adenosine diphosphate. J Physiol 1970; 209: 487–511
- Patscheke H, Dubler D, Deranleau Luscher E F. Optical shape change analysis in stirred and unstirred human platelet suspensions. A comparison of aggregometric and stopped-flow turbidimetric measurements. Thromb Res 1984; 33: 341–53
- Lloyd J V., Nishizawa E E., Mustard J F. Efifect of ADP-induced shape change on incorporation of 32P into platelet phosphatidic acid and mono-di- and triphosphatidyl inositol. Br J Haematol 1977; 25: 77–99
- Holme S, Sixma J J., Wester J, Holmsen H. ADP-induced refractory state of platelets in vitro. II. Functional and ultra studies on gel filtered platelets. Scand J Haematol 1977; 18: 267–78
- Kjeldsberg C R., Swanson J. Platelet sateUitism. Blood 1974; 43: 831–6
- Mende S, Döring M, Thomas H. Granulocyten-Plattchen-Rosetten (‘Plattchen-Satelhten’) als Ursache einer scheinbaren Thrombocytopenie. Klin Wochenschr 1975; 53: 343–5
- Greipp P R., Gralnick H R. Platelet to leukocyte adherence phenomena associated with thrombocytopenia. Blood 1976; 47: 513–21
- Payne C M. Platelet sateUitism. An ultrastructural study. Am J Pathol 1981; 103: 116–28
- Silverstein R L., Nachman R L. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest 1987; 79: 867–74
- Vigdahl R L., Marquis N R., Tavormina P A. Platelet aggregation. II. Adenyl cyclase, prostaglandin E,and calcium. Biochem Biophys Res Commun 1969; 37: 409–15
- Kinlough-Rathbone R L., Packham M A., Mustard J F. The effect of prostaglandin Et on platelet function in vitro and in vivo. Br J Haematol 1970; 19: 559–71
- Gulyas H, Labedza M, Gercken G. Depression of alveolar macrophage hydrogen peroxide and superoxide anion release by mineral dusts: correlation with antimony, lead, and arsenic contents. Environ Res 1990; 51: 218–29
- Martin T R., Altaian L C., Albert R K., Henderson W R. Leukotriene B4 production by the human alveolar macrophage: a potential mechanism for amplifying inflammation in the lung. Am Rev RespirDis 1984; 129: 106–11
- Kotloff R M., Little J, Elias J A. Human alveolar macrophage and blood monocyte interleukin-6 production. Am J Respir Cell Mol Biol 1990; 3: 497–505
- Mac Arthur C, Gray L, Cohen A B. Synthesis and secretion of high- and low-molecular-weight forms of the enzyme-releasing peptide (ERP) from the macrophage-like cell line THP-1. Am J Respir Cell Mol Biol 1991; 4: 18–25